Skip to main content

Table 2 The comparison of hematological parameters of study participants at University Gondar comprehensive specialized referral hospital leishmaniasis research and treatment center Northwest Ethiopia, 2019

From: Hematological profiles of visceral leishmaniasis patients before and after treatment of anti-leishmanial drugs at University of Gondar Hospital; Leishmania Research and Treatment Center Northwest, Ethiopia

Parameters

Pre-treatment

Post-treatment

P value

Total WBCs (103/µl)

2.26 ± 1.04

3.94 ± 1.76

 < 0.001

ALC (103/µl)

0.94 ± 0.45

1.44 ± 0.65

 < 0.001

ANC (103/µl)

1.04 ± 0.71

0.48 ± 0.38

 < 0.001

MID (103/µl)

0.24 ± 0.19

0.48 ± 0.37

 < 0.001

RBCs (106/µl)*

3.35 ± 0.81

3.77 ± 0.83

 < 0.001

Hb (g/dl)*

8.9 ± 2.22

10.5 ± 2.08

 < 0.001

Hct (%)*

27.27 ± 6.49

32.2 ± 6.77

 < 0.001

MCV (fl)

82.35 ± 8.63

85.49 ± 8.26

 < 0.001

MCH (pg)

26.96 ± 4.11

28.05 ± 2.5

 < 0.001

MCHC %*

32.5 ± 1.95

32.7 ± 2.77

0.116

Plt (103/µl)*

97.75 ± 65.86

230.3 ± 109.4

 < 0.001

  1. WBC white blood cell, ANC absolute neutrophil, ALC absolute lymphocyte, MID Absolute monocyte, basophil, and eosinophil, RBC red blood cell, Hb hemoglobin, Hct hematocrit, MCV mean cell volume, MCH mean cell hemoglobin, MCHC mean cell hemoglobin concentration, SD standard deviation, IQR inter quartile range; *Indicates normally distributed data presented with mean and standard deviation. P-value, 0.05 considered statistically significant